This company has been marked as potentially delisted and may not be actively trading. CTI BioPharma (CTIC) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Brainstorm Cell Therapeutics Inc (BCLI) Q4 2024 Earnings Call Highlights: Navigating Financial ...April 1, 2025 | gurufocus.comQ4 2024 Brainstorm Cell Therapeutics Inc Earnings Call TranscriptApril 1, 2025 | gurufocus.comLineage Cell Therapeutics Inc (LCTX) Q4 2024 Earnings Call Highlights: Strategic Advances and ...March 11, 2025 | gurufocus.comQ4 2024 Lineage Cell Therapeutics Inc Earnings Call TranscriptMarch 11, 2025 | gurufocus.comARMISTICE CAPITAL, LLC Reduces Stake in Brainstorm Cell Therapeutics IncFebruary 15, 2025 | gurufocus.comLineage Cell Therapeutics Inc (LCTX) Q2 2024 Earnings Call Highlights: Strategic Alliances and ...October 9, 2024 | gurufocus.comQ2 2024 Brainstorm Cell Therapeutics Inc Earnings Call TranscriptAugust 17, 2024 | gurufocus.comBrainstorm Cell Therapeutics Inc (BCLI) Q2 2024 Earnings Call Transcript Highlights: ...August 17, 2024 | gurufocus.comQ1 2024 Veracyte Inc Earnings CallMay 8, 2024 | uk.finance.yahoo.comConnect Biopharma Holdings Ltd (CNTB)February 22, 2024 | investing.comTheravance Biopharma Inc TBPHDecember 16, 2023 | morningstar.comCTI Engineering Co Ltd (9621)October 23, 2023 | uk.investing.comSEC Charges Former Attorney at U.S.-Based Global Law Firm with Insider TradingAugust 23, 2023 | stockhouse.comSwedish Orphan Biovitrum AB: Sobi completes acquisition of CTI BioPharma Corp.June 27, 2023 | finanznachrichten.deSobi completes acquisition of CTI BioPharma Corp.June 26, 2023 | finance.yahoo.comTrading was temporarily halted for "CTIC" at 07:06 PM with a stated reason of "News pending."June 26, 2023 | marketbeat.com1,405,859 Shares in CTI BioPharma Corp. (NASDAQ:CTIC) Purchased by AIGH Capital Management LLCAIGH Capital Management LLC acquired a new position in shares of CTI BioPharma Corp. (NASDAQ:CTIC - Get Rating) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 1,405,859 shares of the biopharmaceutical company's stock, valued at approximately $8,449,0June 15, 2023 | marketbeat.comCTI BioPharma (CTIC) was upgraded to a Hold Rating at Stifel NicolausJune 7, 2023 | markets.businessinsider.comSwiss National Bank Invests $1.33 Million in CTI BioPharma Corp. (NASDAQ:CTIC)Swiss National Bank bought a new position in shares of CTI BioPharma Corp. (NASDAQ:CTIC - Get Rating) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 221,000 shares of the biopharmaceutical company's stMay 30, 2023 | marketbeat.comStifel Nicolaus upgrades CTI BioPharma (CTIC) to a HoldMay 30, 2023 | markets.businessinsider.comCTI BioPharma Corp. (NASDAQ:CTIC) Shares Sold by Blair William & Co. ILBlair William & Co. IL lessened its stake in CTI BioPharma Corp. (NASDAQ:CTIC - Get Rating) by 24.8% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 132,413 shares of the biopharmaceutical company's stock after selling 43May 29, 2023 | marketbeat.comUBS Group AG Increases Stock Position in CTI BioPharma Corp. (NASDAQ:CTIC)UBS Group AG boosted its stake in CTI BioPharma Corp. (NASDAQ:CTIC - Get Rating) by 542.1% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 926,309 shares of the biopharmaceutical company's stMay 28, 2023 | marketbeat.comCTI BioPharma (NASDAQ:CTIC) Receives New Coverage from Analysts at StockNews.comStockNews.com initiated coverage on CTI BioPharma in a research report on Friday. They set a "hold" rating for the company.May 26, 2023 | marketbeat.comSwedish Orphan Biovitrum AB: Sobi commences tender offer for all outstanding shares of common stock of CTI BioPharma Corp.May 25, 2023 | finanznachrichten.deSobi commences tender offer for all outstanding shares of common stock of CTI BioPharma Corp.May 25, 2023 | finance.yahoo.comArizona State Retirement System Buys New Position in CTI BioPharma Corp. (NASDAQ:CTIC)Arizona State Retirement System bought a new stake in shares of CTI BioPharma Corp. (NASDAQ:CTIC - Get Rating) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 25,821 shares of the biopharmaceutical company's sMay 25, 2023 | marketbeat.comJMP Securities Maintains CTI BioPharma (CTIC) Market Perform RecommendationMay 24, 2023 | msn.comState Board of Administration of Florida Retirement System Invests $70,000 in CTI BioPharma Corp. (NASDAQ:CTIC)State Board of Administration of Florida Retirement System acquired a new position in shares of CTI BioPharma Corp. (NASDAQ:CTIC - Get Rating) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 11,580 shares oMay 24, 2023 | marketbeat.comJMP Securities Keeps Their Hold Rating on CTI BioPharma (CTIC)May 24, 2023 | markets.businessinsider.comSectoral Asset Management Inc. Acquires 12,000 Shares of CTI BioPharma Corp. (NASDAQ:CTIC)Sectoral Asset Management Inc. raised its holdings in shares of CTI BioPharma Corp. (NASDAQ:CTIC - Get Rating) by 1.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 980,300 shares of the biopharmaceutical comMay 22, 2023 | marketbeat.comCTI BioPharma: $1.7bn M&A With 85% Premium, Expect The Deal To Go ThroughMay 16, 2023 | msn.comSVB Leerink Downgrades CTI BioPharma (CTIC)May 16, 2023 | msn.comSVB Securities downgrades CTI BioPharma (CTIC) to a HoldMay 16, 2023 | markets.businessinsider.comSHAREHOLDER ALERT: Weiss Law Investigates CTI BioPharma Corp.May 16, 2023 | marketwatch.comStifel Downgrades CTI BioPharma (CTIC)May 15, 2023 | msn.comThe Latest Analyst Ratings for CTI BioPharmaMay 15, 2023 | markets.businessinsider.comNeedham Downgrades CTI BioPharma (CTIC)May 12, 2023 | msn.comUnusual Call Option Trade in CTI BioPharma (CTIC) Worth $312.39KMay 12, 2023 | msn.comSweden's SOBI offers $1.7 bln to buy CTI BioPharmaMay 11, 2023 | reuters.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating CTI BioPharma Corp. BuyoutMay 11, 2023 | benzinga.comCTI BioPharma (CTIC) was downgraded to a Hold Rating at JMP SecuritiesMay 11, 2023 | markets.businessinsider.comCTI BioPharma Corp. (NASDAQ:CTIC) Receives Average Recommendation of "Moderate Buy" from BrokeragesShares of CTI BioPharma Corp. (NASDAQ:CTIC - Get Rating) have been assigned a consensus recommendation of "Moderate Buy" from the nine ratings firms that are currently covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a hold rating and six have givenMay 11, 2023 | marketbeat.comCTI BioPharma shares soar 83% after Swedish Orphan Biovitrum announces $1.7 billion deal for the biotechMay 10, 2023 | msn.comCTI BioPharma Soars on $1.7B Acquisition by Orphan BiovitrumMay 10, 2023 | msn.comCTI BioPharma to be acquired by Swedish drug company for $1.7BMay 10, 2023 | bizjournals.comWhy Shares of CTI BioPharma Are Soaring WednesdayMay 10, 2023 | finance.yahoo.comWhy Is CTI BioPharma (CTIC) Stock Up 85% Today?May 10, 2023 | investorplace.comSweden's SOBI makes $1.7 bln offer to buy CTI BioPharmaMay 10, 2023 | reuters.comSwedish Orphan Biovitrum AB To Acquire CTI BioPharmaMay 10, 2023 | markets.businessinsider.comSwedish drugmaker finds alluring poison pillMay 10, 2023 | reuters.com Get CTI BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CTIC and its competitors with MarketBeat's FREE daily newsletter. Email Address CTIC Media Mentions By Week CTIC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CTIC News Sentiment▼0.000.84▲Average Medical News Sentiment CTIC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CTIC Articles This Week▼00▲CTIC Articles Average Week Get CTI BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CTIC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Cytokinetics News Ionis Pharmaceuticals News Alkermes News Elanco Animal Health News Prestige Consumer Healthcare News Rhythm Pharmaceuticals News PTC Therapeutics News Perrigo News Ultragenyx Pharmaceutical News Zai Lab News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CTIC) was last updated on 4/29/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CTI BioPharma Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share CTI BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CTIC Stock Free CTIC Stock Alerts